Brief: Inovio Pharmaceuticals Q3 EPS USD -0.87
10/11/2025 21:05
Nov 10 (Reuters) - Inovio Pharmaceuticals Q3 net income USD -45.5 million. Q3 operating expenses USD 21.2 million
Recent news on Inovio Pharmaceuticals
See all newsBrief: Inovio Announces Favorable Judgment In Litigation With Vgxi, Inc. And Geneone Life Science
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Inovio Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Inovio Q2 net loss narrows on warrant gain, lower costs
Brief: Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million